Endothelial Drp1 Couples VEGF-induced Redox Signaling with Glycolysis Through Cysteine Oxidation to Drive Angiogenesis
Sheela NagarkotiiD, Young-Mee KimiD, Archita DasiD, Dipankar AshiD, Eric A. VitrioliD, Tracy‐Ann ReadiD, Sudhahar VaradarajaniD, Md. Selim HossainiD, Shikha YadaviD, Maggie McMenaminiD, Kelvin Orji, Maritza Josefina RomeroiD, Rudolf LucasiD, D. W. A. Stepp, Eric J. Belin de Chantemele, Ruth B. CaldwelliD, David JR. Fulton, Masuko Ushio‐FukaiiD
Abstract
Angiogenesis plays a vital role for postnatal development and tissue repair following ischemia. Reactive oxygen species (ROS) generated by NADPH oxidases (NOXes) and mitochondria act as signaling molecules that promote angiogenesis in endothelial cells (ECs) which mainly relies on aerobic glycolysis for ATP production. However, the connections linking redox signaling with glycolysis are not well understood. The GTPase Drp1 is a member of the dynamin superfamily that moves from cytosol to mitochondria through posttranslational modifications to induce mitochondrial fission. The role of Drp1 in ROS-dependent VEGF signaling and angiogenesis in ECs has not been previously described. Here, we identify an unexpected function of endothelial Drp1 as a redox sensor, transmitting VEGF-induced H2O2 signals to enhance glycolysis and angiogenesis. Loss of Drp1 expression in ECs inhibited VEGF-induced angiogenic responses. Mechanistically, VEGF rapidly induced the NOX4-dependent sulfenylation (CysOH) of Drp1 on Cys644, promoting disulfide bond formation with the metabolic kinase AMPK and subsequent sulfenylation of AMPK at Cys299/304 via the mitochondrial fission-mitoROS axis. This cysteine oxidation of AMPK, in turn, enhanced glycolysis and angiogenesis. In vivo, mice with EC-specific Drp1 deficiency or CRISPR/Cas9-engineered "redox-dead" (Cys to Ala) Drp1 knock-in mutations exhibited impaired retinal angiogenesis and post-ischemic neovascularization. Our findings uncover a novel role for endothelial Drp1 in linking VEGF-induced mitochondrial redox signaling to glycolysis through a cysteine oxidation-mediated Drp1-AMPK redox relay, driving both developmental and reparative angiogenesis.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 5
- FWCI
- 0.58
- Field percentile
- top 40%
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Chemical inhibition of prolyl hydroxylases impairs angiogenic competence of human vascular endothelium through metabolic reprogramming
Ratnakar Tiwari, Prashant V. Bommi, … Pinelopi P. Kapitsinou·bioRxiv·Mar 25, 2022
- Myeloid DRP1 Sulfenylation Drives Reparative Macrophage Polarization and Neovascularization in Ischemic Muscle
Shikha Yadav, Kamarajan Rajagopal, … Masuko Ushio‐Fukai·AntioxidantsPeer-reviewed·Jun 19, 2026
- Reconstituted high-density lipoproteins rescue diabetes-impaired endothelial cell metabolic reprograming and angiogenic responses to hypoxia
K. R. Primer, Joanne T. M. Tan, … Christina A. Bursill·Arteriosclerosis Thrombosis and Vascular BiologyPeer-reviewed·Mar 20, 2025
- MT4-MMP-mediated NRP1 shedding fine-tunes VEGFA signaling dynamics during embryonic brain angiogenesis
Emma Muñoz‐Sáez, Natalia Moracho, … Cristina Sánchez‐Camacho·bioRxiv·May 4, 2026
- Heme synthesis inhibition blocks angiogenesis via mitochondrial dysfunction
T. Shetty, K. Sishtla, … T. W. Corson·bioRxiv·Nov 9, 2019
- DCBLD1 modulates angiogenesis by regulating of the VEGFR-2 endocytosis in endothelial cells
Qi Feng, Lingling Guo, … Lei Nie·bioRxiv·Apr 20, 2023